193 related articles for article (PubMed ID: 18318662)
1. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.
Linsel-Nitschke P; Götz A; Medack A; König IR; Bruse P; Lieb W; Mayer B; Stark K; Hengstenberg C; Fischer M; Baessler A; Ziegler A; Schunkert H; Erdmann J
Clin Sci (Lond); 2008 Nov; 115(10):309-15. PubMed ID: 18318662
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population.
Li Y; Xu X; Zhang D; Cheng W; Zhang Y; Yu B; Zhang Y
Lipids Health Dis; 2019 Jan; 18(1):25. PubMed ID: 30678701
[TBL] [Abstract][Full Text] [Related]
3. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.
Girelli D; Martinelli N; Trabetti E; Olivieri O; Cavallari U; Malerba G; Busti F; Friso S; Pizzolo F; Pignatti PF; Corrocher R
Eur J Hum Genet; 2007 Sep; 15(9):959-66. PubMed ID: 17505527
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
Zee RY; Cheng S; Hegener HH; Erlich HA; Ridker PM
Stroke; 2006 Aug; 37(8):2007-11. PubMed ID: 16778124
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific association of depression and a haplotype in leukotriene A4 hydrolase gene.
Zhao J; Quyyumi AA; Patel R; Zafari AM; Veledar E; Onufrak S; Shallenberger LH; Jones L; Vaccarino V
Psychosom Med; 2009 Sep; 71(7):691-6. PubMed ID: 19622707
[TBL] [Abstract][Full Text] [Related]
6. The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility.
Holloway JW; Barton SJ; Holgate ST; Rose-Zerilli MJ; Sayers I
Allergy; 2008 Aug; 63(8):1046-53. PubMed ID: 18547289
[TBL] [Abstract][Full Text] [Related]
7. The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos.
Via M; De Giacomo A; Corvol H; Eng C; Seibold MA; Gillett C; Galanter J; Sen S; Tcheurekdjian H; Chapela R; Rodríguez-Santana JR; Rodríguez-Cintrón W; Thyne S; Avila PC; Choudhry S; González Burchard E;
Clin Exp Allergy; 2010 Apr; 40(4):582-9. PubMed ID: 20067482
[TBL] [Abstract][Full Text] [Related]
8. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients.
Lõhmussaar E; Gschwendtner A; Mueller JC; Org T; Wichmann E; Hamann G; Meitinger T; Dichgans M
Stroke; 2005 Apr; 36(4):731-6. PubMed ID: 15731479
[TBL] [Abstract][Full Text] [Related]
9. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population.
Helgadottir A; Gretarsdottir S; St Clair D; Manolescu A; Cheung J; Thorleifsson G; Pasdar A; Grant SF; Whalley LJ; Hakonarson H; Thorsteinsdottir U; Kong A; Gulcher J; Stefansson K; MacLeod MJ
Am J Hum Genet; 2005 Mar; 76(3):505-9. PubMed ID: 15640973
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction.
Maznyczka A; Mangino M; Whittaker A; Braund P; Palmer T; Tobin M; Goodall AH; Bradding P; Samani NJ
Clin Sci (Lond); 2007 Jun; 112(7):411-6. PubMed ID: 17176247
[TBL] [Abstract][Full Text] [Related]
11. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
Crosslin DR; Shah SH; Nelson SC; Haynes CS; Connelly JJ; Gadson S; Goldschmidt-Clermont PJ; Vance JM; Rose J; Granger CB; Seo D; Gregory SG; Kraus WE; Hauser ER
Hum Genet; 2009 Mar; 125(2):217-29. PubMed ID: 19130089
[TBL] [Abstract][Full Text] [Related]
12. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
Tsai AK; Li N; Hanson NQ; Tsai MY; Tang W
Atherosclerosis; 2009 Dec; 207(2):487-91. PubMed ID: 19596330
[TBL] [Abstract][Full Text] [Related]
13. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
Helgadottir A; Manolescu A; Thorleifsson G; Gretarsdottir S; Jonsdottir H; Thorsteinsdottir U; Samani NJ; Gudmundsson G; Grant SF; Thorgeirsson G; Sveinbjornsdottir S; Valdimarsson EM; Matthiasson SE; Johannsson H; Gudmundsdottir O; Gurney ME; Sainz J; Thorhallsdottir M; Andresdottir M; Frigge ML; Topol EJ; Kong A; Gudnason V; Hakonarson H; Gulcher JR; Stefansson K
Nat Genet; 2004 Mar; 36(3):233-9. PubMed ID: 14770184
[TBL] [Abstract][Full Text] [Related]
14. ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
Tcheurekdjian H; Via M; De Giacomo A; Corvol H; Eng C; Thyne S; Chapela R; Rodriguez-Cintron W; Rodriguez-Santana JR; Avila PC; Burchard EG;
J Allergy Clin Immunol; 2010 Oct; 126(4):853-8. PubMed ID: 20810156
[TBL] [Abstract][Full Text] [Related]
15. No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population.
Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
Genet Med; 2007 Feb; 9(2):123-9. PubMed ID: 17304054
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations.
Bevan S; Dichgans M; Wiechmann HE; Gschwendtner A; Meitinger T; Markus HS
Stroke; 2008 Apr; 39(4):1109-14. PubMed ID: 18323512
[TBL] [Abstract][Full Text] [Related]
17. Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia.
van der Net JB; Versmissen J; Oosterveer DM; Defesche JC; Yazdanpanah M; Aouizerat BE; Steyerberg EW; Malloy MJ; Pullinger CR; Kane JP; Kastelein JJ; Sijbrands EJ
Atherosclerosis; 2009 Apr; 203(2):472-8. PubMed ID: 18775537
[TBL] [Abstract][Full Text] [Related]
18. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
Hakonarson H; Thorvaldsson S; Helgadottir A; Gudbjartsson D; Zink F; Andresdottir M; Manolescu A; Arnar DO; Andersen K; Sigurdsson A; Thorgeirsson G; Jonsson A; Agnarsson U; Bjornsdottir H; Gottskalksson G; Einarsson A; Gudmundsdottir H; Adalsteinsdottir AE; Gudmundsson K; Kristjansson K; Hardarson T; Kristinsson A; Topol EJ; Gulcher J; Kong A; Gurney M; Thorgeirsson G; Stefansson K
JAMA; 2005 May; 293(18):2245-56. PubMed ID: 15886380
[TBL] [Abstract][Full Text] [Related]
19. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population.
Kajimoto K; Shioji K; Ishida C; Iwanaga Y; Kokubo Y; Tomoike H; Miyazaki S; Nonogi H; Goto Y; Iwai N
Circ J; 2005 Sep; 69(9):1029-34. PubMed ID: 16127181
[TBL] [Abstract][Full Text] [Related]
20. PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.
Kostulas K; Gretarsdottir S; Kostulas V; Manolescu A; Helgadottir A; Thorleifsson G; Gudmundsson LJ; Thorsteinsdottir U; Gulcher JR; Stefansson K; Hillert J
J Neurol Sci; 2007 Dec; 263(1-2):113-7. PubMed ID: 17655870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
